<div class="responsive-container">
  <table class="table5" id="Cluster_Diff">
    <thead>
      <tr>
        <th colspan="3" class="table-title" style="text-align: center;">
          High-Yield CD Markers – Step 1
        </th>
      </tr>
      <tr>
        <th>CD Marker</th>
        <th>Cell / Function</th>
        <th>Clinical Relevance</th>
      </tr>
    </thead>
    <tbody>
      <tr><td>CD1a</td><td>Langerhans cells</td><td>Seen in Langerhans cell histiocytosis (Birbeck granules)</td></tr>
      <tr><td>CD3</td><td>All T cells (part of TCR complex)</td><td>PAN-T cell marker (e.g., T-ALL)</td></tr>
      <tr><td>CD4</td><td>Helper T cells</td><td>HIV targets CD4+ cells</td></tr>
      <tr><td>CD5</td><td>T cells, subset of B cells</td><td>Expressed in CLL/SLL (B-cell tumor with aberrant CD5)</td></tr>
      <tr><td>CD8</td><td>Cytotoxic T cells</td><td>Viral immunity, MHC I restricted</td></tr>
      <tr><td>CD10</td><td>Pre-B cells, germinal center B cells</td><td>Positive in ALL, follicular lymphoma</td></tr>
      <tr><td>CD11b</td><td>Myeloid, monocytes</td><td>Adhesion and migration; ↑ in myelomonocytic leukemias</td></tr>
      <tr><td>CD13</td><td>Myeloid lineage</td><td>Positive in AML (granulocytic marker)</td></tr>
      <tr><td>CD14</td><td>Macrophages</td><td>Binds LPS (endotoxin receptor)</td></tr>
      <tr><td>CD15</td><td>Granulocytes</td><td>Also positive in Hodgkin lymphoma</td></tr>
      <tr><td>CD16</td><td>NK cells, neutrophils</td><td>Fc receptor for ADCC</td></tr>
      <tr><td>CD18</td><td>Integrin (leukocytes)</td><td>Deficient in LAD type 1 (leukocyte adhesion deficiency)</td></tr>
      <tr><td>CD19</td><td>B cells</td><td>Used in B cell lineage cancers (e.g., B-ALL)</td></tr>
      <tr><td>CD20</td><td>B cells (mature)</td><td>Target of rituximab (e.g., lymphomas)</td></tr>
      <tr><td>CD21</td><td>B cells, EBV receptor</td><td>EBV entry point (mono, Burkitt)</td></tr>
      <tr><td>CD23</td><td>Mature B cells</td><td>Distinguishes CLL (CD5+CD23+) from mantle cell (CD5+CD23−)</td></tr>
      <tr><td>CD25</td><td>Tregs, activated T cells</td><td>IL-2 receptor, dysregulation in autoimmunity</td></tr>
      <tr><td>CD28</td><td>T cells</td><td>Binds B7 for costimulation</td></tr>
      <tr><td>CD30</td><td>Activated B and T cells</td><td>Positive in Reed-Sternberg cells (Hodgkin lymphoma)</td></tr>
      <tr><td>CD31</td><td>Endothelial cells</td><td>Marker for angiosarcoma</td></tr>
      <tr><td>CD33</td><td>Myeloid precursor cells</td><td>Target of gemtuzumab ozogamicin (AML therapy)</td></tr>
      <tr><td>CD34</td><td>Stem cells, endothelial precursors</td><td>Used in stem cell markers</td></tr>
      <tr><td>CD34</td><td>Hematopoietic stem cells</td><td>Stem cell marker for bone marrow transplants</td></tr>
      <tr><td>CD38</td><td>Plasma cells</td><td>Multiple myeloma marker</td></tr>
      <tr><td>CD55/CD59</td><td>Complement regulatory proteins</td><td>Deficient in PNH</td></tr>
      <tr><td>CD56</td><td>NK cells</td><td>Specific NK marker (CD16+/CD56+)</td></tr>
      <tr><td>CD79a</td><td>B cells</td><td>Present in most B-cell neoplasms</td></tr>
      <tr><td>CD117 (c-Kit)</td><td>Stem cells, mast cells</td><td>Seen in GIST (gastrointestinal stromal tumors)</td></tr>
      <tr><td>CD138</td><td>Plasma cells</td><td>Multiple myeloma marker</td></tr>
    </tbody>
</table>

<br><br>
<table class="table5" id="CD_Neoplasm_Associations">
  <thead>
    <tr>
      <th colspan="3" class="table-title" style="text-align: center;">
        CD Marker Patterns in Neoplasms
      </th>
    </tr>
    <tr>
      <th>CD Markers</th>
      <th>Neoplasm</th>
      <th>Notes</th>
    </tr>
  </thead>
  <tbody>
    <tr><td>CD15+, CD30+</td><td>Hodgkin Lymphoma (Reed-Sternberg)</td><td>Classic form; not in NLPHL</td></tr>
    <tr><td>CD10+, CD19+, CD20+</td><td>Follicular Lymphoma</td><td>BCL2 overexpression</td></tr>
    <tr><td>CD5+, CD20+, CD23+</td><td>Chronic Lymphocytic Leukemia (CLL)</td><td>B-cell malignancy with aberrant CD5</td></tr>
    <tr><td>CD5+, CD20+, CD23–</td><td>Mantle Cell Lymphoma</td><td>t(11;14) cyclin D1</td></tr>
    <tr><td>CD19+, CD20+, variably CD10+/–</td><td>Diffuse Large B-cell Lymphoma (DLBCL)</td><td>Most common NHL</td></tr>
    <tr><td>CD10+, CD19+, TdT+</td><td>Acute Lymphoblastic Leukemia (ALL)</td><td>Common in children</td></tr>
    <tr><td>CD13+, CD33+, MPO+</td><td>Acute Myeloid Leukemia (AML)</td><td>Myeloid lineage</td></tr>
    <tr><td>CD11c+, CD25+, CD103+</td><td>Hairy Cell Leukemia</td><td>TRAP stain+, dry tap</td></tr>
    <tr><td>CD38+, CD138+</td><td>Multiple Myeloma</td><td>Plasma cell neoplasm</td></tr>
    <tr><td>CD20+</td><td>Primary CNS Lymphoma</td><td>AIDS-defining; EBV-related</td></tr>
  </tbody>
</table>
</div>